Down From Highs, SoFi Grows Into Long-Term Profit Push
SoFi posted stronger Q1 2026 results, but the stock remains depressed as investors weigh the path to sustained profit...
Which Is Better Target Date Funds Or Age Based Strategy
Which Is Better Target Date Funds Or Age Based Strategy: Brief. A quick look at the trade-offs between these approaches to help you decide what suits you.
27,345 articles
NVIDIA, Intel, Marvell, and Other AI Stocks Plunged Today
The AI rally cooled as major chip makers like NVIDIA, Intel, and Marvell pulled back. This article breaks down why th...
Palantir Stock Fallen More: Is This Long-Term AI Buy Signal?
Palantir has seen a sizable pullback, but the real question for patient AI investors is whether this move creates a d...
Ferroglobe Stock Winner Wednesday: A Deep Momentum Dive
Investors flocked to Ferroglobe after a midweek earnings update, turning a measured bounce into a genuine momentum pl...
Under Greg Abel, Apple and Alphabet Berkshire Portfolio
Berkshire Hathaway is changing under Greg Abel, shifting toward concentrated bets on Apple and Alphabet. This article...
NuScale Power Next Nuclear: Is This the Investment That Could Pay Dividends?
As AI and data demand surge, investors eye NuScale Power and the small modular reactor trend. Can nuscale power next ...
Is CoreWeave Underrated Artificial Intelligence Stock?
As AI demands surge, CoreWeave positions itself as a specialized cloud provider for GPU compute. This article digs in...
Micron Makes Trillion Club Momentum: A Crowded Club
The trillion-dollar club is crowded and growing. If micron makes trillion club, it could reshape memory stock bets an...
Alltoscan Announces Token Burn to Trim ATS Supply
Alltoscan revealed a deflationary plan to reduce ATS supply from 100 million to 30 million through phased burns funde...
Bath Beyond-Fathom Deal Part of New Ecosystem Push
Bed Bath & Beyond breaches traditional retail boundaries with an all-stock acquisition of Fathom Holdings, signaling ...
AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Billionaire Warren Buffett Disciple Urges Side Hustle First
A prominent follower of Buffett’s value approach argues for a side hustle that can replace a salary, not a sudden qui...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status